NO843673L - Fremgangsmaate ved fremstilling av terapeutisk aktive doser med forsinket frigjoering - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktive doser med forsinket frigjoering

Info

Publication number
NO843673L
NO843673L NO843673A NO843673A NO843673L NO 843673 L NO843673 L NO 843673L NO 843673 A NO843673 A NO 843673A NO 843673 A NO843673 A NO 843673A NO 843673 L NO843673 L NO 843673L
Authority
NO
Norway
Prior art keywords
procedure
drug
preparation
delayed release
therapeutic active
Prior art date
Application number
NO843673A
Other languages
English (en)
Inventor
Jerry L Sheumaker
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NO843673L publication Critical patent/NO843673L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO843673A 1983-09-16 1984-09-14 Fremgangsmaate ved fremstilling av terapeutisk aktive doser med forsinket frigjoering NO843673L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53286483A 1983-09-16 1983-09-16

Publications (1)

Publication Number Publication Date
NO843673L true NO843673L (no) 1985-03-18

Family

ID=24123487

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843673A NO843673L (no) 1983-09-16 1984-09-14 Fremgangsmaate ved fremstilling av terapeutisk aktive doser med forsinket frigjoering

Country Status (16)

Country Link
EP (1) EP0139881B1 (no)
JP (1) JPH0688901B2 (no)
KR (1) KR910003557B1 (no)
AT (1) ATE42894T1 (no)
AU (1) AU565487B2 (no)
CA (1) CA1221632A (no)
DE (1) DE3478085D1 (no)
DK (1) DK164019C (no)
FI (1) FI843609L (no)
IE (1) IE57445B1 (no)
IL (1) IL71886A (no)
MX (1) MX171030B (no)
NO (1) NO843673L (no)
NZ (1) NZ208155A (no)
PH (1) PH20237A (no)
ZA (1) ZA844023B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
CA1331563C (en) * 1987-08-03 1994-08-23 Gaylen M. Zentner Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
SE9103110D0 (sv) 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
GB2360894B (en) * 2000-03-30 2004-11-10 Peter Thomas Bosson Display device support system
MX2009013019A (es) * 2007-05-30 2010-04-01 Neos Therapeutics Lp Modificacion de liberacion de farmaco en suspensiones de sistemas de resina ionica.
WO2013088271A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3138525A (en) * 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
FR5227M (no) * 1966-03-18 1967-08-14
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations

Also Published As

Publication number Publication date
DK434784D0 (da) 1984-09-12
KR910003557B1 (ko) 1991-06-05
IL71886A (en) 1987-11-30
ZA844023B (en) 1985-03-27
KR850002399A (ko) 1985-05-13
NZ208155A (en) 1987-09-30
MX171030B (es) 1993-09-27
EP0139881A1 (en) 1985-05-08
JPH0688901B2 (ja) 1994-11-09
IE841201L (en) 1985-03-16
FI843609A0 (fi) 1984-09-14
EP0139881B1 (en) 1989-05-10
AU565487B2 (en) 1987-09-17
ATE42894T1 (de) 1989-05-15
DE3478085D1 (en) 1989-06-15
IE57445B1 (en) 1992-09-09
DK164019B (da) 1992-05-04
JPS6067418A (ja) 1985-04-17
DK434784A (da) 1985-03-17
PH20237A (en) 1986-11-10
FI843609L (fi) 1985-03-17
CA1221632A (en) 1987-05-12
IL71886A0 (en) 1984-09-30
DK164019C (da) 1992-09-28
AU2789184A (en) 1985-03-21

Similar Documents

Publication Publication Date Title
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156752B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
DE69000881D1 (de) 2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO843673L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive doser med forsinket frigjoering
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO151367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive syreaddisjonsslater av 16beta-monokvaternaere ammoniumderivater av 2beta,16beta-bis-piperidino-5alfa-androstaner
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO162155C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
NO164982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO159590C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive fenyleddiksyre-derivater.
NO152839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
DE3166825D1 (en) Process for manufacture of a coated acetylsalicylic-acid formulation
NO161258C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive 1-pyridyloksy-3-indolylalkylamino-2-propanol-derivater.
NO159588C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 5-okso-2-pyrrolidin-propansyrederivater.
NO160139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive akridanonderivater.
NO164599C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.